Cohort Primary Hyperparathyroidism
Condition(s):Primary HyperparathyroidismLast Updated:July 21, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Primary HyperparathyroidismLast Updated:July 21, 2022Recruiting
Condition(s):Primary HyperparathyroidismLast Updated:June 22, 2022Completed
Condition(s):Hyperparathyroidism, PrimaryLast Updated:August 30, 2023Recruiting
Condition(s):Primary Hyperparathyroidism; Osteoporosis, PostmenopausalLast Updated:January 30, 2024Active, not recruiting
Condition(s):Primary HyperparathyroidismLast Updated:December 5, 2023Completed
Condition(s):Multigland Disease in Primary HyperparathyroidismLast Updated:August 25, 2017Withdrawn
Condition(s):Primary HyperparathyroidismLast Updated:January 27, 2010Completed
Condition(s):Primary HyperparathyroidismLast Updated:July 30, 2018Unknown status
Condition(s):Primary Hyperparathyroidism; Type 2 DiabetesLast Updated:July 6, 2023Recruiting
Condition(s):Primary HyperparathyroidismLast Updated:March 9, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.